Treatment of Mesenchymal Stem Cell-Derived Extracellular Vesicles with Extract of Cultured Lentinula edodes Modulates Breast Cancer Stem Cells and MicroRNA Reprogramming

用培养的香菇提取物处理间充质干细胞来源的细胞外囊泡可调节乳腺癌干细胞和microRNA重编程

阅读:1

Abstract

Breast carcinoma represents the most frequent malignancy in women in Canada, and intrinsic or acquired drug resistance significantly increases the risk of recurrence and metastasis. Although front-line therapy is multimodal, chemoresistance remains a major hurdle in treatment and therapy, and the intake of natural compounds resulting from fermentation processes is currently considered an effective strategy to overcome this problem. This study investigated the effect of extracellular vesicles (EVs) from Mesenchymal Stromal/stem cells (MSCs) pretreated with cultured Lentinula edodes extract (AHCC) on reducing chemoresistance and modulating microRNAs in the MCF-7 and MCF-7/DOX cell lines. EV characterization was performed using nanoparticle tracking analysis, and microRNAs and the formation of cancer stem cells were studied. The miRNA analysis revealed that AHCC significantly downregulated oncogenic miR-155 but upregulated the tumor-suppressive microRNAs miR-34a, miR-Let7a, and miR-200c. In vitro experiments showed inhibition of cancer stem cell proliferation after challenging the cells with AHCC-pretreated EVs. Conclusion: Our data demonstrated that AHCC may contribute to modulation of the tumor microenvironment, thus influencing the development of cancer stem cells.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。